Effectiveness and impact of the 4CMenB vaccine against invasive serogroup B meningococcal disease and gonorrhoea in an infant, child, and adolescent programme: an observational cohort and case-control study

Evaluating the effectiveness of the 4CMenB vaccine against invasive meningococcal disease and gonorrhoea in an infant, child and adolescent program: protocol

(2021) Helen S. Marshall et al.   Human Vaccines & Immunotherapeutics

High coverage of diverse invasive meningococcal serogroup B strains by the 4-component vaccine 4CMenB in Australia, 2007–2011: Concordant predictions between MATS and genetic MATS

(2021) Sarah J. Tozer et al.   Human Vaccines & Immunotherapeutics

First statewide meningococcal B vaccine program in infants, children and adolescents: evidence for implementation in South Australia

(2020) Helen S Marshall et al.   MEDICAL JOURNAL OF AUSTRALIA

Vaccination of Infants with Meningococcal Group B Vaccine (4CMenB) in England

(2020) Shamez N. Ladhani et al.   NEW ENGLAND JOURNAL OF MEDICINE

Meningococcal B Vaccine and Meningococcal Carriage in Adolescents in Australia

(2020) Helen S. Marshall et al.   NEW ENGLAND JOURNAL OF MEDICINE

The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination

(2020) Sydel R. Parikh et al.   JOURNAL OF INFECTION

Gonococcal vaccines: Public health value and preferred product characteristics; report of a WHO global stakeholder consultation, January 2019

(2020) Sami L. Gottlieb et al.   VACCINE

Effectiveness and Impact of the 4CMenB Vaccine against Group B Meningococcal Disease in Two Italian Regions Using Different Vaccination Schedules: A Five-Year Retrospective Observational Study (2014–2018)

(2020) Chiara Azzari et al.   Vaccines

Association of Use of a Meningococcus Group B Vaccine With Group B Invasive Meningococcal Disease Among Children in Portugal

(2020) Fernanda M. P. Rodrigues et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Impact of meningococcal B vaccine on invasive meningococcal disease in adolescents

(2020) Mark McMillan et al.   CLINICAL INFECTIOUS DISEASES

Case fatality rates of invasive meningococcal disease by serogroup and age: A systematic review and meta-analysis

(2019) Bing Wang et al.   VACCINE

Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016

(2019) Jane Rowley et al.   BULLETIN OF THE WORLD HEALTH ORGANIZATION

Impact of a mass vaccination campaign against Serogroup B meningococcal disease in the Saguenay-Lac-Saint-Jean region of Quebec four years after its launch

(2019) G. Deceuninck et al.   VACCINE

Genetic Similarity of Gonococcal Homologs to Meningococcal Outer Membrane Proteins of Serogroup B Vaccine

(2019) Henju Marjuki et al.   mBio

Immunogenicity and safety of the multicomponent meningococcal B vaccine (4CMenB) in children and adolescents: a systematic review and meta-analysis

(2018) Maria Elena Flacco et al.   LANCET INFECTIOUS DISEASES

The serogroup B meningococcal vaccine Bexsero elicits antibodies to Neisseria gonorrhoeae

(2018) Evgeny A Semchenko et al.   CLINICAL INFECTIOUS DISEASES

Varicella vaccine effectiveness over 10 years in Australia; moderate protection from 1-dose program

(2018) Helen E. Quinn et al.   JOURNAL OF INFECTION

Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study

(2017) Helen Petousis-Harris et al.   LANCET

Possible Impact of Wide-scale Vaccination Against Serogroup B Neisseria Meningitidis on Gonorrhea Incidence Rates in One Region of Quebec, Canada

(2017) Jean Longtin et al.   Open Forum Infectious Diseases

Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study

(2016) Sydel R Parikh et al.   LANCET

The potential impact of vaccination on the prevalence of gonorrhea

(2015) Andrew P. Craig et al.   VACCINE

Potential impact of vaccination against Neisseria meningitidis on Neisseria gonorrhoeae in the United States: Results from a decision-analysis model

(2014) Stéphane A Régnier et al.   Human Vaccines & Immunotherapeutics

The changing and dynamic epidemiology of meningococcal disease

(2011) Scott A. Halperin et al.   VACCINE